62 related articles for article (PubMed ID: 1758064)
1. [Hodgkin's disease associated with LDH-M subunit deficiency].
Arai N; Hara A; Umeda M; Shirai T
Rinsho Ketsueki; 1991 Nov; 32(11):1521-5. PubMed ID: 1758064
[TBL] [Abstract][Full Text] [Related]
2. 14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group.
Sieber M; Bredenfeld H; Josting A; Reineke T; Rueffer U; Koch T; Naumann R; Boissevain F; Koch P; Worst P; Soekler M; Eich H; Müller-Hermelink HK; Franklin J; Paulus U; Wolf J; Engert A; Diehl V;
J Clin Oncol; 2003 May; 21(9):1734-9. PubMed ID: 12721249
[TBL] [Abstract][Full Text] [Related]
3. [Studies of patients with non-Hodgkin's lymphoma unresponsive to C-MOPP].
Shirakawa S; Shimizu K; Shinkai K; Kojima H; Maruyama F; Sobue R; Ito N; Imura H; Matsui T; Ino T
Rinsho Ketsueki; 1988 Jul; 29(7):1025-30. PubMed ID: 3184470
[No Abstract] [Full Text] [Related]
4. Pilot study of modified version of CHOP plus radiotherapy for early-stage aggressive non-Hodgkin's lymphoma of the head and neck.
Nishioka T; Tsuchiya K; Nishioka S; Kitahara T; Ohmori K; Homma A; Aoyma H; Shindoh M; Shirato H
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):847-52. PubMed ID: 15465202
[TBL] [Abstract][Full Text] [Related]
5. [Malignant lymphoma of the testis: report of two cases].
Ito H; Fuse H; Hirano S; Masuda S; Takeshima M
Hinyokika Kiyo; 1997 Aug; 43(8):599-603. PubMed ID: 9310787
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of two different ProMACE-CytaBOM derived regimens in advanced aggressive non-Hodgkin's lymphoma. Final report of a multicenter trial conducted by GISL.
Federico M; Clò V; Brugiatelli M; Carotenuto M; Gobbi PG; Vallisa D; Lombardo M; Avanzini P; Di Renzo N; Dini D; Baldini L; Silingardi V
Haematologica; 1998 Sep; 83(9):800-11. PubMed ID: 9825577
[TBL] [Abstract][Full Text] [Related]
7. Impact of three courses of intensified CHOP prior to high-dose sequential therapy followed by autologous stem-cell transplantation as first-line treatment in poor-risk, aggressive non-hodgkin's lymphoma: comparative analysis of Dutch-Belgian Hemato-Oncology Cooperative Group Studies 27 and 40.
van Imhoff GW; van der Holt B; Mackenzie MA; Van't Veer MB; Wijermans PW; Ossenkoppele GJ; Schouten HC; Sonneveld P; Steijaert MM; Kluin PM; Kluin-Nelemans HC; Verdonck LF;
J Clin Oncol; 2005 Jun; 23(16):3793-801. PubMed ID: 15809447
[TBL] [Abstract][Full Text] [Related]
8. [CVP or C-MOPP combination chemotherapy in the treatment of advanced Hodgkin's disease and non-Hodgkin's lymphoma (intermediate grade of working formulation)].
Sampi K; Honda T; Hattori M
Rinsho Ketsueki; 1984 Feb; 25(2):164-8. PubMed ID: 6547984
[No Abstract] [Full Text] [Related]
9. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E
Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727
[TBL] [Abstract][Full Text] [Related]
10. Atypical presentation of Hodgkin's disease in a patient at risk for the acquired immunodeficiency syndrome.
Keyserlingk H; Ludwig WD; Seibt H; Rühl H; Höffken G
Cancer Detect Prev; 1988; 12(1-6):243-8. PubMed ID: 3180129
[TBL] [Abstract][Full Text] [Related]
11. [Tumor lysis syndrome after treatment for mediastinal non-Hodgkin's lymphoma].
Kaneki T; Hachiya T; Hayano T; Koizumi T; Kubo K; Harada T; Kawashima A; Sekiguchi M; Honda T; Maruyama Y
Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Apr; 35(4):414-9. PubMed ID: 9212666
[TBL] [Abstract][Full Text] [Related]
12. [A bulky mass non-Hodgkin's lymphoma with dysuria in the rectovesical space].
Tosaka A; Yamazaki A; Hirokawa M; Matsushita K; Asakura S
Hinyokika Kiyo; 1990 Jun; 36(6):701-5. PubMed ID: 2239564
[TBL] [Abstract][Full Text] [Related]
13. [Non-Hodgkin's lymphoma in a patient after many years of remission of Hodgkin's disease].
Kaźmierczak M; Komarnicki M; Kroll R
Acta Haematol Pol; 1995; 26(3):311-3. PubMed ID: 8525778
[TBL] [Abstract][Full Text] [Related]
14. [Short-term result of non-Hodgkin's lymphoma treated by the COMP regimen].
Tang WY; He GF; Din GX; Sun ZY
Zhonghua Zhong Liu Za Zhi; 1987 Mar; 9(2):140-2. PubMed ID: 3652916
[TBL] [Abstract][Full Text] [Related]
15. [Chemotherapy of stage III-IV Hodgkin's disease. A retrospective analysis of the 53 cases collected from 9 institutions in Japan].
Takagi T; Ohnoshi T; Hayashi K; Ohtake S; Sampi K; Sawada U; Kuraishi Y; Kondo M; Suzuki H; Oyama A
Rinsho Ketsueki; 1989 Jul; 30(7):994-8. PubMed ID: 2681883
[TBL] [Abstract][Full Text] [Related]
16. [A case of Hodgkin's disease with an uncommon clinical course. Predominant localization in the liver].
Marjańska-Radziszewska J; Zawiła K; Cieśla E
Przegl Lek; 1996; 53(11):830-2. PubMed ID: 9173449
[TBL] [Abstract][Full Text] [Related]
17. Pediatric Hodgkin's disease.
Oliapuram Jose B; Koerner P; Bertolone S; Patel CC; Spanos WJ; Paris KJ; Silverman CL; Yashar CM
J Ky Med Assoc; 2004 Mar; 102(3):104-6. PubMed ID: 15067795
[TBL] [Abstract][Full Text] [Related]
18. [A retrospective analysis of the treatment results in Hodgkin's disease in a radiotherapy clinic].
Mjaaland I; Ganser D; Freitag EM; Bohndorf W
Strahlenther Onkol; 1994 Sep; 170(9):516-23. PubMed ID: 7524173
[TBL] [Abstract][Full Text] [Related]
19. A variant of ProMACE-CytaBOM chemotherapy for non-Hodgkin's lymphoma with threefold higher drug dose size but identical cumulative dose intensity. A pilot study of the Italian lymphoma study group (GISL).
Gobbi PG; Ghirardelli ML; Avanzini P; Baldini L; Quarta G; Stelitano C; Broglia C; Loni C; Silingardi V; Ascari E
Haematologica; 2000 Mar; 85(3):263-8. PubMed ID: 10702814
[TBL] [Abstract][Full Text] [Related]
20. [Complete remission of relapsed mixed cellularity Hodgkin's disease treated with rituximab].
Al-Ali HK; Wittekind C; Niederwieser D
Dtsch Med Wochenschr; 2007 Aug; 132(33):1688-91. PubMed ID: 17713864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
